Report
AstraZeneca opens new R&D site in Kendall Square
STAT reports the opening celebrated a $1 billion investment after a spate of Chinese dealmaking.
TLDR
STAT reports AstraZeneca opened the Kendall Square site on October 5, 2026, celebrating a $1 billion investment in an unsettled center of U.S. biotechnology. The opening followed a spate of Chinese dealmaking.
Combined views
1.8K
1 Source, first seen ago